| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a method for treating, pretreating or preconditioning, or preventing an erythropoietin-related condition, and to provide a compound used in these methods and a method for identifying such a compound. <P>SOLUTION: The compound increases an endogenous erythropoietin in vitro and in vivo, which is selected from the group consisting of, for example, heterocyclic carboxamides, phenanthrolines, hydroxamates and biologically active-salts, and prodrugs derived from these. <P>COPYRIGHT: (C)2011,JPO&INPIT</p> |
